Presentation Information
[28P-am174]Development of a brain-targeting formulation of the VIPR2 inhibitory peptide KS-133 for the recovery of cognitive dysfunction in schizophrenia model mice
○Kotaro Sakamoto1, Takatsugu Hirokawa2, Zihao Jin3, Rei Yokoyama4, Shinsaku Nakagawa3, Yukio Ago4, Eijiro Miyako5 (1. Ichimaru Pharcos co. Ltd., 2. Unv of Tsukuba, 3. Osaka Univ., 4. Hiroshima Univ., 5. JAIST)
Password required to view
Enter the password to view the abstracts.
The password will be emailed to those who have completed the registration.
The password will be emailed to those who have completed the registration.